Table: Aska Pharmaceutical Holdings - 6-MTH group results

ASKA Pharmaceutical Holdings

06/11/2023 06:00

Nov 6 (Reuters)- 
             Aska Pharmaceutical Holdings Co., Ltd. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended       Year to 
                Sep 30, 2023        Sep 30, 2022     Mar 31, 2024 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             31.65               30.17            62.00    
                 (+4.9 pct)          (+6.0 pct)       (+2.5 pct)  
  Operating          3.06                2.88             5.40    
                 (+6.1 pct)          (+8.3 pct)       (+5.7 pct)  
  Recurring          3.10                2.99             5.50    
                 (+3.6 pct)          (+8.9 pct)       (+5.1 pct)  
  Net                4.13                2.35             6.20    
                 (+76.0 pct)                          (+46.3 pct) 
  EPS            145.93 yen           83.18 yen       219.08 yen  
  Ann Div                             16.00 yen        40.00 yen  
  -Q2 div         20.00 yen           8.00 yen                    
  -Q4 div                             8.00 yen         20.00 yen  
  
  NOTE - Aska Pharmaceutical Holdings Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4886.T